$40.0M
The round was led by F-Prime Capital to support the development of novel therapeutics for disordered proteins.
"By taking a rigorous and computer-driven experimental physics approach to analysing proteins, we can go beyond classical drug discovery approaches and observe protein behaviour that algorithms like AlphaFold cannot. This new funding will allow us to further advance our platform and support the investigation of the disordered protein universe towards developing drugs of the future,"
F-Prime Capital + 3 others
